Scientific Program
Sunday, May 14, 2000, 2.30 - 4.00 p.m.
Room 42.A

4th European Congress of Oto-Rhino-Laryngology, Head and Neck Surgery


Experimental therapy strategies I

Chairperson: A.Cambioni, Rome/Italy
Co-Chairperson: B.Wollenberg, Munich/Germany

Time Number Title, Author
2.30 - 4.00 p.m. 303. Liposomal doxorubicin in the palliative treatment of head and neck cancer
J. Büntzel, S. Bäsecke, R. Weinaug, M. Glatzel, et al., Suhl/Germany
304. Influence of tenascin on proliferation and migration in head and neck tumors
S. Eichhorn, M. M. Müller, C. Reisser, C. Herold-Mende, Heidelberg/Germany
305. "Magnetic drug targeting" - a model of local tumor-therapy
C. Alexiou, W. Arnold, R. Klein, A. Lübbe, et al., Munich, Bad Lippspringe/Germany
306. Association between Bleomycin-induced chromosome instability and histological aggressions in laryngeal cancer
P. Dabrowski, W. Szyfter, Z. Szmeja, K. Szyfter, Poznan/Poland
307. Docetaxel and Cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
D. Thurnher, J. Kornfehl, M. Formanek, B. Knerer, et al., Vienna/Austria
308. Photodynamic therapy with Foscan® (temoporfin) in primary squamous cell carcinoma of the head and neck
A. Kübler, Cologne/Germany
309. Photochemotherapy of head and neck cancer: a comparision between new photosensitizers
I. P. Gräber, A. A. Eshraghi, D. J. Castro, Berlin, Paris, Los Angeles, Germany/France/USA
310. Foscan-mediated photodynamic therapy (Foscan-PDT) in recurrent and 2nd primary oral cavity cancers
B.Tan, Amsterdam/The Netherlands
311. Hyperthermia enhances chemotherapeutic cytotoxicity on human squamous cell carcinomas xenografts in nude mice
K. Sommer, M. Raap, S. Remmert, G. Wiedemann, Lübeck/Germany

4.00 - 4.30 p.m. Coffee Break


>> To Sunday's overview     >> To overall program overview


EUFOS 2000 Homepage | 71st Annual Meeting German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. All contents copyright © 1998-2000. All rights reserved.